People: Two Biochemists Share Columbia's 1989 Horwitz Prize

Columbia University's Louisa Gross Horwitz Prize for 1989 has been awarded to Edwin G. Krebs and Alfred G. Gilman, two biochemists whose lifelong research has traced and explained the intricate communication network that regulates critical processes in living cells. The prize, given by a committee of Columbia medical and science professors, is one of the awards that observers cite as a forerunner to the winning of the Nobel Prize. Twenty-three of the award's winners have gone on to become Nobel

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Columbia University's Louisa Gross Horwitz Prize for 1989 has been awarded to Edwin G. Krebs and Alfred G. Gilman, two biochemists whose lifelong research has traced and explained the intricate communication network that regulates critical processes in living cells. The prize, given by a committee of Columbia medical and science professors, is one of the awards that observers cite as a forerunner to the winning of the Nobel Prize. Twenty-three of the award's winners have gone on to become Nobel laureates.

Krebs, 71, is a senior investigator at the Howard Hughes Medical Institute and professor of pharmacology at the University of Washington. Gilman is chairman of the Department of Pharmacology at the University of Texas Southwestern Medical Center at Dallas. The two scientists will share the $22,000 award, given annually for outstanding research in biology or biochemistry.

Krebs was cited for his work on protein phosphorylation, a process that activates ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies